Ads
related to: vertex pharmaceuticals news- Our Company
Learn about our mission and
the values that drive us.
- News
Stay current on all things Vertex
and discover the latest news.
- Contact Us
Find all the ways to reach us
for the information you need.
- Our Unique Approach
See What Makes Us Unique
And How We Put Science First.
- Our Company
Search results
Could This News Upset Vertex Pharmaceuticals' Prospects in the Billion-Dollar Pain Management...
Motley Fool via Yahoo Finance· 3 months agoVertex Pharmaceuticals (NASDAQ: VRTX) is the global leader in cystic fibrosis (CF) treatment, and...
Vertex Pharmaceuticals: Buy at the High?
Motley Fool· 1 year agoVertex Pharmaceuticals (NASDAQ: VRTX) has a lot going on these days. The biotech company is developing two candidates that could make it even stronger in...
Vertex Pharmaceuticals Just Lost a Potential Rival. Is the Stock a Buy?
Motley Fool· 1 year agoVertex Pharmaceuticals (NASDAQ: VRTX) is the global leader in cystic fibrosis (CF) treatment. The...
Vertex Pharmaceuticals Just Proved Something Big to Investors. Time to Buy?
Motley Fool· 5 months agoVertex Pharmaceuticals (NASDAQ: VRTX) has built a billion-dollar cystic fibrosis (CF) treatment...
Is Vertex Pharmaceuticals Stock a Millionaire Maker?
Motley Fool via Yahoo Finance· 4 weeks agoVertex Pharmaceuticals (NASDAQ: VRTX) is a growing pharmaceutical company with a robust cystic fibrosis (CF) business that generated nearly $10 billion...
Is Vertex Pharmaceuticals a Buy?
Motley Fool· 1 year agoVertex Pharmaceuticals (NASDAQ: VRTX) has beaten the bear market by far this year: The stock is heading for a 30% gain. Vertex is the global leader in...
Is Vertex Pharmaceuticals Stock a Buy Now?
Motley Fool via Yahoo Finance· 4 months agoBiotech giant Vertex Pharmaceuticals (NASDAQ: VRTX) has delivered market-beating returns over the past 12 months, five years, and 10 years. Existing...
2 Green Flags for Vertex Pharmaceuticals' Future
Motley Fool· 2 years agoBiotech Vertex Pharmaceuticals (NASDAQ: VRTX) is defying the stock market sell-off this year. While that's great news for shareholders, it's essential to...
This Growth Stock Crushed the Market Last Year. 5 Words from the CEO Suggest There's More to Come.
Motley Fool· 1 year agoVertex Pharmaceuticals (NASDAQ: VRTX) stock climbed more than 31% last year even as the overall...
Vertex Pharmaceuticals Stock Sees Rising Relative Strength
Investor's Business Daily· 1 year agoVertex Pharmaceuticals stock saw a positive improvement to its Relative Strength (RS) Rating on...
Ad
related to: vertex pharmaceuticals news
